Back

Go back

What products will remain within Pfizer PAP as of January 1, 2025?

Question

Answer

Type	Primary Care	Specialty Care	Oncology
Medicines	Celontin Depo-Estradiol Duavee Estring Norpace CR Nurtec Premarin Premphase Prempro Synarel Tikosyn Trecator Zarontin Zavzpret	BeneFIX Cibinqo Elelyso Eucrisa Litfulo Somavert Velsipity Vyndaqel / Vyndamax Xeljanz Xyntha	Adcetris Besponsa Bosulif Braftovi Daurismo Ibrance Inlyta Lorbrena Mektovi Mylotarg Talzenna Tivdak Tukysa Vizimpro Xalkori
Vaccines	Abrysvo Comirnaty Penbraya Prevnar 20 Trumenba

NOTE: This list of products is subject to change

updates

19